# Asian Institute of Gastroenterology, India: Phase 3 study started recruiting, 134 planned (Pancreatitis, Chronic, Exocrine Pancreatic Insufficiency (EPI))

**Score:** 85/100

| Field | Value |
|---|---|
| Sponsor | Asian Institute of Gastroenterology, India |
| Sponsor type | Academic and hospital |
| Study | Comparative Study to Evaluate Microbial Versus Porcine Pancreatic Enzyme Therapy in Chronic Pancreatitis |
| NCT ID | NCT07697352 |
| Phase | Phase 3 |
| Status | recruiting |
| Conditions | Pancreatitis, Chronic; Exocrine Pancreatic Insufficiency (EPI) |
| Intervention types | dietary supplement, other |
| Target enrollment | 134 |
| Site countries | India |
| Posted | 2026-07-13 |
| Planned start | 2026-10-12 |
| Event | Started recruiting |
| Event date | 2026-10-12 |
| Last update posted | 2026-10-26 |

## Why this score
- Posted in the last two weeks.
- Just started recruiting: sites, recruitment and supply are active.
- Phase 3: multi-site, larger budget.
- 134 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07697352). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.